Search filters

List of works by Lisa Vandermeer

A cost-utility analysis of risk model-guided versus physician's choice antiemetic prophylaxis in patients receiving chemotherapy for early-stage breast cancer: a net benefit regression approach.

scientific article

A multi-center pragmatic, randomized, feasibility trial comparing standard of care schedules of filgrastim administration for primary febrile neutropenia prophylaxis in early-stage breast cancer.

scientific article

A multi-centre, randomised trial comparing schedules of G-CSF (filgrastim) administration for primary prophylaxis of chemotherapy-induced febrile neutropenia in early stage breast cancer

scientific article published on 20 April 2020

A multicentre, randomized pilot trial comparing vascular access strategies for early stage breast cancer patients receiving non-trastuzumab containing chemotherapy

scientific article published on 07 August 2019

A phase 2 trial exploring the clinical and correlative effects of combining doxycycline with bone-targeted therapy in patients with metastatic breast cancer.

scientific article published on July 2016

A phase II, multicentre trial evaluating the efficacy of de-escalated bisphosphonate therapy in metastatic breast cancer patients at low-risk of skeletal-related events.

scientific article published on 18 March 2014

A randomised trial of 4- versus 12-weekly administration of bone-targeted agents in patients with bone metastases from breast or castration-resistant prostate cancer

scientific article published on 03 October 2020

A randomized clinical trial comparing physician-directed or fixed-dose steroid replacement strategies for incomplete dexamethasone dosing prior to docetaxel chemotherapy

scientific article published on 15 October 2020

A randomized trial comparing vascular access strategies for patients receiving chemotherapy with trastuzumab for early-stage breast cancer

scientific article published on 30 January 2020

A randomized, double-blind, phase II, exploratory trial evaluating the palliative benefit of either continuing pamidronate or switching to zoledronic acid in patients with high-risk bone metastases from breast cancer

scientific article published on 7 December 2015

A scoping review characterizing "Choosing Wisely®" recommendations for breast cancer management

scientific article published on 06 November 2020

Applying Serum Cytokine Levels to Predict Pain Severity in Cancer Patients

scientific article published on 07 February 2020

Choice of study endpoint significantly impacts the results of breast cancer trials evaluating chemotherapy-induced nausea and vomiting

scientific article published on 5 January 2016

Cost analysis of using Magee scores as a surrogate of Oncotype DX for adjuvant treatment decisions in women with early breast cancer

scientific article published on 09 July 2019

Creating a pragmatic trials program for breast cancer patients: Rethinking Clinical Trials (REaCT)

scientific article published on 24 May 2019

De-escalation of bone-modifying agents in patients with bone metastases from breast cancer: a systematic review and meta-analysis

scientific article published on 11 May 2019

Detection of PIK3CA Mutations in Breast Cancer Bone Metastases

scientific article published on 30 August 2012

Does integration of Magee equations into routine clinical practice affect whether oncologists order the Oncotype DX test? A prospective randomized trial

scientific article published on 23 January 2019

Effects of de-escalated bisphosphonate therapy on bone turnover biomarkers in breast cancer patients with bone metastases

scientific article

Effects on bone resorption markers of continuing pamidronate or switching to zoledronic acid in patients with high risk bone metastases from breast cancer

scientific article published on 8 November 2017

Enhancing accrual to chemotherapy trials for patients with early stage triple-negative breast cancer: a survey of physicians and patients.

scientific article published on 27 January 2017

Excision of the primary tumour in patients with metastatic breast cancer: a clinical dilemma

scientific article

Feasibility of using a pragmatic trials model to compare two primary febrile neutropenia prophylaxis regimens (ciprofloxacin versus G-CSF) in patients receiving docetaxel-cyclophosphamide chemotherapy for breast cancer (REaCT-TC)

scientific article published on 11 August 2018

Filgrastim use in patients receiving chemotherapy for early-stage breast cancer-a survey of physicians and patients.

scientific article published on 6 February 2018

Histomorphometric and microarchitectural analyses using the 2 mm bone marrow trephine in metastatic breast cancer patients-preliminary results

scientific article

Investigating the discernible and distinct effects of platinum-based chemotherapy regimens for metastatic triple-negative breast cancer on time to progression

scientific article published on 07 January 2014

Long-term impact of bone-modifying agents for the treatment of bone metastases: a systematic review

scientific article published on 13 June 2020

Measuring the impact of guideline-based antiemetic therapy on nausea and vomiting control in breast cancer patients with multiple risk factors

scientific article published on 17 September 2015

Novel Methodology for Comparing Standard-of-Care Interventions in Patients With Cancer.

scientific article

Optimal Management of Leptomeningeal Carcinomatosis in Breast Cancer Patients-A Systematic Review.

scientific article

Optimal primary febrile neutropenia prophylaxis for patients receiving docetaxel-cyclophosphamide chemotherapy for breast cancer: a systematic review

scientific article

Optimal sequence of adjuvant endocrine and radiation therapy in early-stage breast cancer - A systematic review

scholarly article by S.F. McGee et al published September 2018 in Cancer Treatment Reviews

Optimal vascular access strategies for patients receiving chemotherapy for early-stage breast cancer: a systematic review

article published in 2018

Optimal vascular access strategies for patients receiving chemotherapy for early-stage breast cancer: a systematic review

Physician Survey of Timing of Adjuvant Endocrine Therapy Relative to Radiotherapy in Early Stage Breast Cancer Patients

scientific article published on 04 September 2018

Preference weights for chemotherapy side effects from the perspective of women with breast cancer.

scientific article

Primary Febrile Neutropenia Prophylaxis for Patients Who Receive FEC-D Chemotherapy for Breast Cancer: A Systematic Review

scientific article published on 21 April 2017

Prospective validation of a prediction tool for identifying patients at high risk for chemotherapy-induced nausea and vomiting

scientific article published in March 2013

Prospective validation of risk prediction indexes for acute and delayed chemotherapy-induced nausea and vomiting.

scientific article

Randomised feasibility trial to compare three standard of care chemotherapy regimens for early stage triple-negative breast cancer (REaCT-TNBC trial)

scientific article published in PLoS ONE

Real-world practice patterns and attitudes towards de-escalation of bone-modifying agents in patients with bone metastases from breast and prostate cancer: A physician survey

scientific article published on 10 November 2020

Risk Model-Guided Antiemetic Prophylaxis vs Physician's Choice in Patients Receiving Chemotherapy for Early-Stage Breast Cancer: A Randomized Clinical Trial

scientific article

Selecting Patients for Oncotype DX Testing Using Standard Clinicopathologic Information

scientific article published on 22 August 2019

Should de-escalation of bone-targeting agents be standard of care for patients with bone metastases from breast cancer? A systematic review and meta-analysis

scientific article published on 28 June 2015

Strategies for obtaining bone biopsy specimens from breast cancer patients - Past experience and future directions

scientific article published on 07 July 2016

Taxane acute pain syndrome (TAPS) in patients receiving chemotherapy for breast or prostate cancer: a prospective multi-center study.

scientific article published on 21 March 2018

Use and Delivery of Granulocyte Colony–Stimulating Factor in Breast Cancer Patients Receiving Neoadjuvant or Adjuvant Chemotherapy—Single-Centre Experience ⬇️

scientific article published on August 1, 2012

Use of conjoint analysis to assess breast cancer patient preferences for chemotherapy side effects.

scientific article published on 28 January 2014

Paulina is supported by:

About Paulina

Help